Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02659540
Title A Pilot Study to Evaluate the Safety and Efficacy of Combination Checkpoint Blockade Plus External Beam Radiotherapy in Subjects With Stage IV Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ludwig Institute for Cancer Research



Ipilimumab + Nivolumab

Age Groups: adult
Covered Countries USA

No variant requirements are available.